Technical Analysis for BSTC - BioSpecifics Technologies Corp

Grade Last Price % Change Price Change
grade A 66.51 0.27% 0.18
BSTC closed up 0.27 percent on Friday, January 18, 2019, on 1.53 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical BSTC trend table...

Date Alert Name Type % Chg
Jan 18 Stochastic Sell Signal Bearish 0.00%
Jan 18 New 52 Week Closing High Bullish 0.00%
Jan 18 Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 NR7 Range Contraction 0.00%
Jan 18 Upper Bollinger Band Walk Strength 0.00%
Jan 18 Inside Day Range Contraction 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%

Older signals for BSTC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase for various clinical indications primarily in the United States. It provides injectable collagenase under the XIAFLEX name for the treatment of adult Dupuytren's contracture patients with a palpable cord. The company also develops XIAFLEX injectable collagenase for Peyronie's disease, frozen shoulder, cellulite, human lipoma, and canine lipoma indications, as well as for keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. to develop, market, and sell injectable collagenase. The company was founded in 1957 and is headquartered in Lynbrook, New York.
Is BSTC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 68.0
52 Week Low 38.05
Average Volume 40,963
200-Day Moving Average 52.0443
50-Day Moving Average 59.8862
20-Day Moving Average 60.64
10-Day Moving Average 62.835
Average True Range 2.9391
ADX 14.66
+DI 28.4271
-DI 13.9711
Chandelier Exit (Long, 3 ATRs ) 59.1827
Chandelier Exit (Short, 3 ATRs ) 61.5273
Upper Bollinger Band 66.6719
Lower Bollinger Band 54.6081
Percent B (%b) 0.99
BandWidth 19.894129
MACD Line 1.4282
MACD Signal Line 0.7762
MACD Histogram 0.652
Fundamentals Value
Market Cap 476.48 Million
Num Shares 7.16 Million
EPS 1.63
Price-to-Earnings (P/E) Ratio 40.80
Price-to-Sales 11.74
Price-to-Book 5.25
PEG Ratio 1.30
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 68.42
Resistance 3 (R3) 68.57 68.10 68.10
Resistance 2 (R2) 68.10 67.61 68.02 67.99
Resistance 1 (R1) 67.30 67.31 67.70 67.15 67.89
Pivot Point 66.83 66.83 67.03 66.75 66.83
Support 1 (S1) 66.03 66.34 66.43 65.88 65.13
Support 2 (S2) 65.56 66.04 65.48 65.03
Support 3 (S3) 64.76 65.56 64.92
Support 4 (S4) 64.61